NCT Number: NCT01217827
Implantable Cardioverter-Defibrillator Use in the VA System
Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon prior research, a major barrier to low utilization is low referral of potential candidates by healthcare providers. In this study, via brief clinical reminder placed in the electronic medical record, we ask healthcare providers who have not referred potential candidates for defibrillator the reasons for this decision and provide them with the tools for referral if appropriate.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
VA Palo Alto Health Care System, Palo Alto, California, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Meeting published criteria for receipt of an implantable cardioverter defibrillator Exclusion Criteria:provider is not affiliated with the VA health care system
Treatment and study plan
Primary outcomes
-
Referral for Implantable Cardioverter Defibrillator
Time frame: 6 months
Referral of the patient to electrophysiology clinic for evaluation for cardioverter defibrillator implantation.
Sponsors and collaborators
Lead sponsor
Stanford University
Other
Collaborators
- Medtronic
- VA Palo Alto Health Care System
Registry information
Official study title
Implantable Cardioverter-Defibrillator (ICD) Utilization in a Potentially Eligible VA Population
Important dates
- Study start
- 2010
- Primary completion
- 2011
- Study completion
- 2013
- First posted
- Oct 8, 2010
- Registry last updated
- May 19, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
NCT04737265
Breast Cancer, Breast Diseases
Duarte, California, United States
View Trial DetailsHealthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy
NCT06893731
Cardiomyopathies, Cardiovascular Diseases
Beijing, China
View Trial DetailsTowards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study
NCT03749551
Cardiomegaly, Cardiomyopathies
Frankfurt am Main, Hesse, Germany
View Trial DetailsAdjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
NCT04166331
Cardiomyopathies, Cardiovascular Diseases
Orléans, Orleans, France
View Trial Details